Patent details

LUC00114 Product Name: doravirine ou un sel pharmaceutiquement acceptable de celle-ci en combinaison avec la lamivudine ou un sel pharmaceutiquement acceptable de celle-ci en combinaison avec du ténofovir ou un de ses esters, en particulier un ester de disoproxil ou un de ses sels pharmaceutiquement acceptables, en particulier un sel de fumarate

Basic Information

Publication number:
LUC00114
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP151573482
Legal Status:
Inactive
Application number:
LUC00114
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/18/1333
Marketing Authorization Type:
Marketing Authorization Date:
26/11/2018
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
17/04/2019
First Marketing Authorization date:
26/11/2018
Grant date:
10/07/2020
Activation date:
Publication date:
17/04/2019
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
26/11/2033
SPC Extension Expiration:
26/11/2033
Rejection date:
Withdrawal date:

Owner

From:
17/04/2019
 
 

Name:
Merck Canada Inc.
Address:
16711 Trans-Canada Highway, Kirkland QC H9H 3L1, Canada (CA)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
17/04/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2019/06
Publication date:
06/05/2019
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2020/09
Publication date:
04/08/2020
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
31/03/2031
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
17/04/2019 General Document 2
17/04/2019 General Document 47
17/04/2019 Outgoing Correspondence 2
10/07/2020 Publication 1
17/04/2019 Publication 1
17/04/2019 Application Form 4
10/07/2020 Outgoing Correspondence 1
17/04/2019 General Document 3
10/07/2020 Certificate 1